The mechanisms underlying the marked increase in [K']. in response to ischemia are not fully understood. Accordingly, the present study was performed to assess the contribution of ATP-regulated K' channels by using simultaneous measurements of cellular K+ efflux, [K'] ,umol * g wet wt-i, p<0.01) but had no significant influence on repolarization time or tissue ATP levels. Although glibenclamide partially prevented action potential shortening induced by hypoxic perfusion in the presence of elevated [K+]., the proportion of cellular K+ efflux reduced by glibenclamide was less (23%) than that observed with glibenclamide in hypoxic perfusion with normal [K']. (44%). These findings indicate that 1) APD remained relatively normal after 15 minutes of hypoxia despite the fact that cellular K' loss was markedly greater and ATP content was significantly less than during ischemia, suggesting that neither ATP depletion nor cellular K' loss per se is responsible for shortening of repolarization during ischemia, and 2) [K+L, accumulation is responsible for the shortening of repolarization that also inhibits cellular K+ loss. (Circulation Research 1993;72:560-570) 
Yan et al Cellular K' Loss During Hypoxia and Ischemia 561 enclamide and tolbutamide prevent both the shortening of the transmembrane action potential and the increase in [K']0 during ischemia. [3] [4] [5] Despite data supporting a role of the ATP-sensitive K' channels in modulation of action potential duration and in unidirectional K' efflux, several unexplained questions persist. These include the following: 1) whether the moderate reduction in [ATP] during early ischemia6-9 opens a sufficient number of ATP-sensitive K' channels (Kd at ATP 25-500 ,uM)'0-13 to fully explain the marked action potential shortening that occurs; 2) whether action potential shortening during ischemia might occur secondary to a rise in extracellular K' per se moving through ATP-sensitive K' channels and described by the well-known [K']O-dependent change of the current-voltage relation, leading to a marked increase in the delayed rectifier K' current, IK, and the inward rectifier K' current, IKI1415; and 3) whether opening of a few ATP-sensitive K' channels per cell, as has been hypothesized, is sufficient to elicit a shortening in action potential directly16 and at the same time to account for the marked K' efflux sufficient to explain the rise in [K+] o.
The significance of the role of the ATP-sensitive K' channels in modulating electrophysiological and ionic alterations in the ischemic heart is dependent on the degree of specificity of sulfonylureas at the whole-cell and tissue level, i.e., whether their action is indeed limited to inhibition of sarcolemmal ATP-sensitive K' channels. Several recent investigations indicate that this is not the case. For example, sulfonylureas affect the glycolytic metabolic pathway, protein kinase A activity, and the mitochondrial transport of fatty acids. Glibenclamide stimulates lactate production during normoxia5 but inhibits the increase in lactate production during hypoxia. 17 Tolbutamide has been found to stimulate glycolytic flux and therefore to directly influence energy metabolism. 18 In addition, tolbutamide has been shown to be an inhibitor of cAMP-dependent protein kinase,19 to shorten action potential duration in rabbit papillary muscles,20 and to prolong action potential duration in rat ventricular muscle under normoxic conditions. 21 Sulfonylureas also inhibit carnitine acyltransferase, which catalyzes the conversion of acyl coenzyme A and carnitine to long-chain acylcarnitine and would be expected to modify the increase in long-chain acylcarnitines during hypoxia or ischemia. 22 Accordingly, the present study was undertaken to determine the mechanisms underlying the shortening in action potential duration during myocardial ischemia and to determine whether the net efflux of cellular K' is due to opening of ATP-sensitive K' channels. The experiments were performed using simultaneous measurements of net K' efflux, [K'] ., action potential duration, and tissue ATP, ADP, and phosphocreatine content in an isolated blood-perfused papillary muscle preparation. Our results indicate that net efflux of K' is largest in hypoxia, when changes in action potential duration are minimal, and that action potential shortening is a direct consequence of the rise in [K+] o rather than the opening of ATP-sensitive K' channels.
Materials and Methods
Preparation and Perfusion of Papillary Muscles
The methods for the preparation of the isolated arterially perfused rabbit papillary muscle have been described in detail previously.23 '24 Briefly, rabbits weighing 2-3 kg were anticoagulated with heparin (200 units/kg i.v.) and anesthetized with pentobarbital (50 mg/kg i.v.). The hearts were excised, placed in cold (4°C) Tyrode's solution with 8.5 mM K', and transported to a dissection tray. The atria, left and right ventricular free walls, and the nonperfused portion of the right ventricle were removed. The left ventricular septal surface of the tissue was attached to a wax platform that contained the ground electrode. The septal artery was cannulated and perfused with a solution of the following composition: insulin (1 unit/I), heparin (400 units/l), albumin (Mr, 67,000; 26.8 g/l), dextran (Mr, 70,000; 15 g/l), sodium palmitate (167 mg/l), and Tyrode's solution containing (mM) Na+ 149, K' 4.5, Mg2+ 0.49, Ca2+ 1.8, Cl-133, HCO3-25, HP042-0.4, and glucose 20. The total ischemic time during excision of the heart and cannulation of the septal artery before perfusion was always less than 4 minutes in each experiment and averaged 3.3 +0.2 minutes in the current series of experiments.
After the preparation was placed in the recording chamber, it was perfused through the septal artery with a solution composed of the previous perfusate plus washed bovine erythrocytes (hematocrit, 25-35%) and surrounded by an artificial gaseous atmosphere consisting of 95% 02-5% CO2 (Figure 1 ). Perfusion pressure was measured with a transducer (Gould, Cleveland, Ohio) and maintained between 40 and 50 mm Hg by adjustment of the perfusion flow rate (0.8-1 ml * min-1 g wet wt-1). This perfusion pressure is considered to be normal for small arteries in the rabbit heart (diameter at the site of cannulation, approximately 150 ,um), because approximately 50% of peripheral vascular resistance is located in the arteries above 150-jum diameter. 25 The tendinous end of the papillary muscle was fixed to a force transducer ( In the experiments designed to assess the effects of hypoxia with maintained flow, hypoxic blood was produced in the absence of a membrane gas exchanger as follows: 100 ml blood was stirred in a 1,000-ml flask and equilibrated for 2 hours with H20-saturated 95% N2-5% CO2 delivered via a gas dispersion tube, the software. Samples (10-50 gl) were injected onto a HI-Pore RP-318 reversed-phase HPLC column (BioRad Laboratories, Richmond, Calif.) and eluted with an isocratic mobile phase of 0.1 M ammonium phosphate, pH 5.5, at a flow rate of 0.5 ml/min. Under these conditions, all phosphometabolites of interest eluted from the column within 20 minutes. Quantification of each metabolite was determined by comparing the integrated peak area to a linear regression curve constructed from the integrated peak areas obtained from injecting 0.2-1.0 nmol phosphocreatine, creatine, ATP, ADP, and AMP standards. Recoveries of nucleotides from the tissue using this method of extraction and quantification were consistently greater than 90%.
The protein content of each muscle was quantified by resuspending the protein pellet obtained from the first centrifugation in 1 ml distilled water using a modified Lowry protein assay. Phosphometabolite levels were corrected for protein content for each muscle and
Experimental Protocol
The papillary muscle preparations were stimulated through a silver wire at the apex of the muscle at a basic cycle length of 500 msec. In each experiment, control measurements were obtained after the preparation had stabilized in the chamber for a minimum of 30 minutes. After 15 minutes of control recording, each muscle was subjected to either 15 minutes of continued normoxic control perfusion, hypoxic perfusion, or no-flow ischemia. For determination of the effects of glibenclamide (Sigma Chemical Co., St. Louis, Mo.) on cellular K' loss and action potential alterations during hypoxia, the preparation was perfused with normoxic blood with glibenclamide (5 ,uM) for at least 20 minutes after the stabilization period before hypoxic perfusion was initiated. Glibenclamide was present throughout the hypoxic perfusion as well. Only a single ischemic or hypoxic period was induced in each preparation. (p<0.01, Table 1 ). Comparison of the changes in action potential duration at 80% of repolarization during hypoxia versus ischemia is depicted in Figure 2C . Previous studies have shown that glibenclamide attenuates the shortening in action potential duration and the extent of cellular K' loss during ischemia. To ascertain whether these effects were due to the reported inhibitory action of glibenclamide on ATPregulated K' channels or to other documented effects on cellular metabolism, glibenclamide (5 ,uM) explanation for these differences is the previous findings that glucose prevents action potential shortening by maintaining glycolysis during hypoxia. In superfused guinea pig papillary muscles, the marked action potential shortening induced by hypoxia can be partially attenuated by increased levels of glucose in the perfusate or enhancement of glycolytic activity.40.4' However, transmembrane action potential configurations recorded from arterially perfused rabbit papillary muscles are not significantly altered during hypoxia, either in the presence or absence of glucose.42 In contrast, marked action potential shortening is observed in the same preparation, when an anoxic erythrocyte-free perfusate was used.42 Thus, an alternative factor that may be important in determining action potential duration during hypoxia is whether the preparations are perfused through their microvascular bed or superfused. Action potentials measured from cells on the surface of a hypoxic preparation may be electrotonically influenced by cells in which action potentials shorten in the anoxic center of the preparation. Thus, heterogeneous distribution of action potential configurations with marked electrotonic interactions will exist in the superfused preparation because of differences in Po2 or metabolite diffusion gradients between the hypoxic surface and the anoxic core. The fact that no action potential shortening occurred after 15 minutes of hypoxia in our study indicates that these preparations, which are uniformly perfused via their native vascular bed, are an ideal model to exclude diffusional gradients that are certain to exist in superfused preparations. Furthermore, differences between buffer perfusion with or without blood cells could contribute as well because of the efficiency of 02 delivery and therefore to potentially greater maintenance of glycolysis in the blood-perfused preparation.
Statistical Analysis
Cellular K' loss during hypoxia has been thought to be one of the major mechanisms underlying the shortening in action potential duration.43,44 However, one unique and striking finding revealed by the present results is that marked cellular K' efflux occurs during hypoxia in the presence of normal action potential duration ( Figure 2 , Table 1 ). That is, net cellular K' loss occurred independent of a change in action potential duration. Activation of ATP-regulated K' channels has been proposed recently as the primary mechanism responsible for cellular K' loss and action potential Figure 6A ) and normoxia at high [K+] , ( Figure   6B ) was the marked reduction in the contribution of phase 0 depolarization to action potential duration. This suggests that the additional shortening in action potential duration in response to hypoxia is partially due to a decrease in Na+ or Ca2`inward currents. [45] [46] [47] Third, tissue ATP levels during hypoxia were not influenced by elevation of [K'], (Table 2) .
Another critical issue related to whether activation of ATP-regulated K+ channels contributes importantly to action potential shortening and cellular K+ loss during hypoxia and ischemia is the relation to intracellular ATP levels. Elliott et a150 found that changes in action potential duration during metabolic blockade were not . In the present study, whole-tissue ATP levels were measured and compared among experimental conditions in which action potentials were obtained from the surface layer of the muscles. Inhomogeneity of ATP levels may have existed in the surface versus the core of ischemic muscles. However, the preparations that were perfused with hypoxic blood through the native vascular bed should have been homogenous with respect to electrical activity and metabolic state. The decrease in tissue ATP levels observed during hypoxia was greater than that measured during ischemia ( Figure  3 , Table 2 ), yet this was not associated with significant changes in action potential duration (Figure 2 ). These findings indicate that action potential shortening is not directly dependent on ATP content in intact bloodperfused tissue. The lower level of ATP during hypoxia may be due to the maintenance of contractile activity during early hypoxia as a result of extracellular washout of K+, H+, C02, and metabolic products or the maintenance of intravascular pressure, which would preclude vascular collapse.51 In other words, the lower level of ATP observed during hypoxia may be a result of continued utilization of ATP in an attempt to maintain contractility in the face of a limited energy supply. Effects of Glibenclamide on Cellular K' Loss and Changes in Action Potential Duration
The hypothesis that cellular K' loss during ischemia is secondary to opening of ATP-regulated K' channels is based primarily on observations that application of glibenclamide or tolbutamine, which have been presumed to be specific inhibitors of this channel, leads to both reversal of action potential shortening due to a membrane potential effect and reduction of cellular K' loss due to a K' flux effect. [3] [4] [5] The present study, as well as reports from other laboratories,5"17-22 indicate that the interpretation of the response to sulfonylureas such as glibenclamide during ischemia is likely to be complex and not solely related to their effects on ATP-regulated K' channels. For example, it was shown that an agent that opens ATPregulated K' channels, cromakalim, actually had no In summary, the present study demonstrated that the greatest cellular K' efflux was observed during hypoxia at normal [K'],, when action potential duration was not significantly altered, whereas marked action potential shortening with less cellular K' loss occurred during no-flow ischemia. Glibenclamide inhibited cellular K+ loss during hypoxia without concomitant changes in action potential duration. Furthermore, tissue ATP levels were significantly lower during hypoxia, with or without action potential shortening, compared with ischemia. In concert, the present study demonstrates a clear dissociation between net cellular K+ loss and action potential shortening during hypoxia. ATP-regulated K+ channels are not likely to be involved in the net cellular K+ loss during hypoxia. Moreover, their role as the major cause of action potential shortening in ischemia or hypoxia is questionable. Finally, glibenclamide, which has multiple effects on membrane function and metabolism in oxygen-deprived tissue, is likely to exert these effects not only via prevention of ATP-regulated K+ channel opening but also via mechanisms such as a reduction in glycolytic rate.
